Showing 1 – 20 of 36
Relevance | Newest | Oldest |
  • Use of Recommended Neurodiagnostic Evaluation Among Patients With Drug-Resistant Epilepsy

    Abstract Full Text
    ÁñÁ«ÊÓƵ Neurol. 2024; 81(5):499-506. 10.1001/jamaneurol.2024.0551

    This cross-sectional study examines the use of neurodiagnostic testing among patients with drug-resistant epilepsy.

  • Risk of Squamous Cell Carcinoma of the Breast Following Postmastectomy Implant Reconstruction in Women With Breast Cancer and Carcinoma in Situ

    Abstract Full Text
    free access
    JAMA Surg. 2023; 158(7):769-771. 10.1001/jamasurg.2023.0262

    This cohort study uses national surveillance data to describe the incidence and risk of squamous cell carcinoma after postmastectomy implant reconstruction in women with breast cancer.

  • Risk of Anaplastic Large Cell Lymphoma Following Postmastectomy Implant Reconstruction in Women With Breast Cancer and Ductal Carcinoma in Situ

    Abstract Full Text
    open access
    ÁñÁ«ÊÓƵ Netw Open. 2022; 5(11):e2243396. 10.1001/jamanetworkopen.2022.43396

    This cohort study examines the risk of anaplastic large cell lymphoma (ALCL) following postmastectomy implant reconstruction among US women with breast cancer and ductal carcinoma in situ (DCIS).

  • Incidence of Anaplastic Large-Cell Lymphoma of the Breast in the US, 2000 to 2018

    Abstract Full Text
    free access
    JAMA Oncol. 2022; 8(9):1354-1356. 10.1001/jamaoncol.2022.2624

    This cohort study of data from the Surveillance, Epidemiology, and End Results 18 database examines the incidence of anaplastic large-cell lymphoma of the breast in the US from 2000 to 2018.

  • Association of Neoadjuvant Chemotherapy With Overall Survival in Women With Metastatic Endometrial Cancer

    Abstract Full Text
    open access
    ÁñÁ«ÊÓƵ Netw Open. 2020; 3(12):e2028612. 10.1001/jamanetworkopen.2020.28612

    This cohort study uses data from the National Cancer Database to investigate the association of neoadjuvant therapy with overall survival in women with metastatic endometrial cancer.

  • Assessment of Electronic Alert to Reduce Overuse of Granulocyte Colony-Stimulating Factor in Patients Hospitalized for Febrile Neutropenia

    Abstract Full Text
    free access
    JAMA Oncol. 2018; 4(7):996-998. 10.1001/jamaoncol.2018.0818

    This study evaluates the efficacy of an alert in the electronic health record to reduce overuse of granulocyte colony-stimulating factor in older patients hospitalized with febrile neutropenia.

  • Nonadherence to Medications for Chronic Conditions and Nonadherence to Adjuvant Hormonal Therapy in Women With Breast Cancer

    Abstract Full Text
    free access
    JAMA Oncol. 2016; 2(10):1326-1332. 10.1001/jamaoncol.2016.1291

    This cohort study uses a large population of women with nonmetastatic breast cancer from the MarketScan database to examine whether adherence to medications for 6 chronic conditions is associated with adherence to adjuvant hormonal therapy.

  • Effect of Regional Hospital Competition and Hospital Financial Status on the Use of Robotic-Assisted Surgery

    Abstract Full Text
    free access
    JAMA Surg. 2016; 151(7):612-620. 10.1001/jamasurg.2015.5508

    This study evaluates associations between measures of hospital competition and financial status and the proportion of radical prostatectomies, nephrectomies, hysterectomies, and oophorectomies that were robotic-assisted.

  • Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study

    Abstract Full Text
    free access
    JAMA Oncol. 2016; 2(9):1170-1176. 10.1001/jamaoncol.2016.0685

    This multisite cohort study of 685 women younger than 70 years with nonmetastatic invasive breast cancer explores whether complementary and alternative medicine use is associated with decreased breast cancer chemotherapy initiation.

  • Targeting the Cancer Moonshot

    Abstract Full Text
    JAMA Oncol. 2016; 2(4):421-422. 10.1001/jamaoncol.2016.0328

    This Viewpoint evaluates prevention as a component of cancer research.

  • Evaluating Chemotherapy at the End of Life—Reply

    Abstract Full Text
    JAMA Oncol. 2016; 2(1):144-144. 10.1001/jamaoncol.2015.4111
  • Chemotherapy Use, Performance Status, and Quality of Life at the End of Life

    Abstract Full Text
    open access
    JAMA Oncol. 2015; 1(6):778-784. 10.1001/jamaoncol.2015.2378

    This multi-institutional, longitudinal cohort study finds that palliative chemotherapy did not improve quality of life near death for cancer patients with moderate or poor performance status and worsened quality of life near death for cancer patients with good performance status.

  • Use of Electric Power Morcellation and Prevalence of Underlying Cancer in Women Who Undergo Myomectomy

    Abstract Full Text
    free access
    JAMA Oncol. 2015; 1(1):69-77. 10.1001/jamaoncol.2014.206

    The prevalence of cancer and precancer of the uterus in women who undergo myomectomy with or without electric power morcellation is low, but risk increases with age, so electric power morcellation should be used with caution in older women undergoing myomectomy.

  • The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ

    Abstract Full Text
    free access
    JAMA Oncol. 2015; 1(3):323-332. 10.1001/jamaoncol.2015.0389

    This cross-sectional study finds that axillary evaluation is often conducted in women treated for ductal carcinoma in situ despite guidelines against its use with breast-conserving surgery and uncertainty of benefit with mastectomy.

  • Aspirin as Adjuvant Therapy for Stage III Colon Cancer: Standard of Care?

    Abstract Full Text
    JAMA Intern Med. 2014; 174(5):739-741. 10.1001/jamainternmed.2013.14544
  • Incidence and Predictors of Bowel Obstruction in Elderly Patients With Stage IV Colon Cancer: A Population-Based Cohort Study

    Abstract Full Text
    free access
    JAMA Surg. 2013; 148(8):715-722. 10.1001/jamasurg.2013.1

    Winner et al conducted a large population-based study to investigate the incidence and risk factors associated with bowel obstruction in elderly patients with stage IV colon cancer. An invited critique by Krouse follows.

  • Black-White Differences in Breast Cancer Outcomes Among Older Medicare Beneficiaries: Does Systemic Treatment Matter?

    Abstract Full Text
    JAMA. 2013; 310(4):376-377. 10.1001/jama.2013.8273
  • Deviations From Guideline-Based Therapy for Febrile Neutropenia in Cancer Patients and Their Effect on Outcomes

    Abstract Full Text
    free access
    JAMA Intern Med. 2013; 173(7):559-568. 10.1001/jamainternmed.2013.2921
    To examine compliance with guideline-based recommendations for febrile neutropenia treatment, explore the factors that influence adherence to consensus guidelines, and analyze how the use of guideline-based care effects the outcome Wright and colleagues reviewed the Perspective database entries of 25 231 cancer patients with febrile neutropenia. See invited commentary by Chen.
  • Robotically Assisted vs Laparoscopic Hysterectomy Among Women With Benign Gynecologic Disease

    Abstract Full Text
    free access has multimedia
    JAMA. 2013; 309(7):689-698. 10.1001/jama.2013.186
    Wright and coauthors examined the use of robotically assisted hysterectomy, its complication profile, and its costs compared with other routes of hysterectomy by performing a cohort study of women who underwent hysterectomy for benign gynecologic disorders from 2007 to 2010. In an Editorial, Weissman and Zinner discuss comparative effectiveness research and robotic surgery.
  • Screening Colonoscopy vs Flexible Sigmoidoscopy—Reply

    Abstract Full Text
    JAMA. 2010; 304(18):2016-2018. 10.1001/jama.2010.1586